HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up

HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up Reviewed and updated July 29, 2026 Abstract Purpose: This review examines how long-acting injectable antiretroviral therapy and injectable HIV pre-exposure prophylaxis are changing treatment, prevention, and adherence frameworks in HIV care. Methodology: The

HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up